Aminopyridazines as Acetylcholinesterase Inhibitors

Journal of Medicinal Chemistry - Tập 42 Số 4 - Trang 730-741 - 1999
Jean‐Marie Contreras1, Yveline Rival1, Saïd Chayer1, Jean‐Jacques Bourguignon1, Camille G. Wermuth1
1Laboratoire de Chimie Organique, ERS 655 du CNRS, Université Louis Pasteur, Faculté de Pharmacie, 74, route du Rhin, 67401 Illkirch-Cedex, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Wermuth C. G., 1972, Le dichlorhydrate de la morpholinoéthylamino-3 méthyl-4 phényl-6 pyridazine (Agr 1240). The dihydrochloride of the morpholinoethylamino-3 methyl-4 phenyl-6 pyridazine (Agr 1240).) Agressologie

Davies P., 1976, Lancet, 2, 1403, 10.1016/S0140-6736(76)91936-X

Avery E. E., 1997, Drugs Agings, 11, 459

Brufani M., 1997, Drugs Future, 22, 410

Parnetti L., 1997, Drugs Future, 53, 768

Giacobini E, 1997, Jpn. J. Pharmacol., 74, 241, 10.1016/S0021-5198(19)31381-2

Garattini S., 1984, Psychopharmacology, 82, 214, 10.1007/BF00427775

Wermuth C. G., 1996, Acta Pharm. Hung., 3, S8

Kan J. P., 1993, Psychopharmacology, 112, 227

Wermuth C. G., 1992, Bioorganic & Med. Chem. Lett., 2, 838, 10.1016/S0960-894X(00)80540-5

Boigegrain R., 1994, Proceedings of the XIIIth International Symposium on Medicinal Chemistry, Paris 1994

Wermuth C. G., 1993, Farmaco, Ed. Sci., 48, 274

Biniecki S., 1961, Acta Polon. Pharmacol., 18, 268

Lespagnol A., 1962, Bull. Soc. Chim. Fr., 1122

Leclerc, G.; Wermuth, C. G. Dérivés pyridaziniques présentant un intérêt thérapeutique. VIII. Action du méthylure de diméthylsulfoxonium sur les phényl-6 pyridazones-3. (Pyridazine Derivatives Presenting a Therapeutic Interest. VIII. Action of Dimethylsulfoxonium Methylide on 6-Phenyl-3(2H)pyridazones.)Bull. Soc. Chim. Fr.1968,10, 4123−4126.

Maghioros, G.; Schlewer, G.; Wermuth, C. G. Obtention sélective d‘hydroxy-4 pyridazinones-3 et de pyridazones-3. Etude des modalités de la cyclocondensation des acides β-acyl lactiques avec l‘hydrazine. (Selective Access to 4-Hydroxy-3(2H)pyridazinones and to 3(2H)pyridazones. Study of the Cyclocondensation Modalities of β-Acyl Lactic Acids with Hydrazine.)Bull. Soc.Chim. Fr.1985,5, 865−870.

Leclerc, G.; Wermuth, C. G. Dérivés pyridaziniques présentant un intérêt thérapeutique. X. Nouvelles synthèses au départ de la méthyl-4 phényl-6 pyridazone-3. (Pyridazine Derivatives Presenting a Therapeutic Interest. X. New Syntheses starting from 4-Methyl-6-phenyl-3(2H)pyridazone.)Bull. Soc. Chim. Fr.1971,5, 1752−1756.

Bourguignon J. J., 1981, J. Org. Chem., 46, 4894, 10.1021/jo00337a013

Wermuth C. G., 1989, J. Med. Chem., 32, 537, 10.1021/jm00123a004

Coates W. J., 1993, Synthesis, 3, 342

Ates C., 1993, Tetrahedron Lett., 34, 5714, 10.1016/S0040-4039(00)73840-8

Church R., 1995, J. Org. Chem., 60, 3758, 10.1021/jo00117a029

Bohne H., 1976, Imminium Salts in Organic Chemistry, 1

Coppola G., 1974, J. Heterocycl. Chem., 11, 56, 10.1002/jhet.5570110111

Coppola G. M., 1979, J. Heterocycl. Chem., 16, 554

Coppola G. M., 1980, J. Heterocycl. Chem., 17, 1482

Andersen T. P., 1983, Tetrahedron, 39, 3427, 10.1016/S0040-4020(01)91595-9

Fatiadi A. J, 1976, Synthesis, 65, 104

Sircar I., 1985, J. Med. Chem., 28, 1413, 10.1021/jm00148a006

Saito T., 1983, J. Heterocycl. Chem., 20, 75, 10.1002/jhet.5570200117

Paudler W. W., 1970, J. Heterocycl. Chem., 7, 769

Glennon R. A., 1988, J. Med. Chem., 31, 1971

Dutta A. K., 1996, J. Med. Chem., 39, 756

Profitt J. A., 1975, J. Org. Chem., 40, 128

Sussman J. L., 1991, Science, 253, 879, 10.1126/science.1678899

Ellman G. L., 1961, Biochem. Pharmacol., 7, 95, 10.1016/0006-2952(61)90145-9

Freeman S. E., 1991, Prog. Neurobiol., 36, 277, 10.1016/0301-0082(91)90002-I

Bryson H. M., 1997, Drugs Aging, 10, 239, 10.2165/00002512-199710030-00007

Sugimoto H., 1996, J. Med. Chem., 38, 4829

Beylin V. G., 1989, J. Heterocycl. Chem., 26, 96, 10.1002/jhet.5570260117

Benarab A., 1993, Amines et Carbamates. (Utilization of the Cyanomethyl Group Motif Protector of Phenols, Amines, and Carbamates.) Tetrahedron Lett.

Surrey A. R., 1954, J. Am. Chem. Soc., 76, 4923

Mokrosz J. L., 1996, J. Med. Chem., 39, 1129, 10.1021/jm950662c

Shapiro S. L., 1959, J. Am. Chem. Soc., 81, 3088

Ueda T., 1967, Chem. Pharm. Bull., 15, 232, 10.1248/cpb.15.228

Finch N., 1973, J. Org. Chem., 38, 440, 10.1021/jo00943a007

Secor H. V., 1994, J. Labeled Compd. Radiopharm., 34, 426, 10.1002/jlcr.2580340503

George P., 1989, leur préparation et leur application en thérapeutique

Valenta V., 1990, Collect. Czech. Chem. Commun., 55, 1310

Wagner S., 1977, J. Am. Chem. Soc., 99, 1862

Eckhardt W., 1974, Chim. Acta, 57, 2345, 10.1002/hlca.19740570805

Garratt P. J., 1986, J. Org. Chem., 51, 552

Sugimoto H., 1990, J. Med. Chem., 33, 1887, 10.1021/jm00169a008

New J. S., 1983, Synthesis, 388, 389

Beyer H., 1957, Chem. Ber., 90, 1742

Malinauskas A. A., 1988, Zh. Org. Khim., 24, 1531

Arnaud-Neu F., 1994, J. Chem. Res. Minipr., 120, 139

Bourguignon J. J., 1988, SANOFI